Join to View Full Profile
5 Franklin AveSuite 609Belleville, NJ 07109
Phone+1 973-751-1410
Fax+1 973-751-9422
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 1 invite waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Michael Miller, MD is an endocrinologist in Belleville, New Jersey. He is currently licensed to practice medicine in New Jersey.
Education & Training
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Endocrinology, Diabetes, and Metabolism, 1984 - 1987- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 1981 - 1984
State University of New York Downstate Medical Center College of MedicineClass of 1981
Certifications & Licensure
NJ State Medical License 1986 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Powerchart, Cerner Healthe and IQHealth, Cerner Corporation, 2012, 2014
- CMS Meaningful Use Stage 1 Certification Powerworks, Cerner Healthe and Cerner Patient Portal, Cerner Corporation, 2012, 2014
- CMS Meaningful Use Stage 1 Certification HealthSentry, Cerner Corporation, 2012, 2014
Publications & Presentations
PubMed
- 6 citationsStructure–Activity Relationship of Novel and Selective Biaryl-Chroman GPR40 AgoPAMsHelen Chen, Christopher W. Plummer, Dong Xiao, Harry R. Chobanian, Duane E. DeMong
ACS Medicinal Chemistry Letters. 2018-06-14 - 22 citationsDesign and Synthesis of Novel, Selective GPR40 AgoPAMs.Christopher W. Plummer, Matthew J. Clements, Helen Chen, Murali Rajagopalan, Josien Hubert B
ACS Medicinal Chemistry Letters. 2017-01-30 - 8 citationsDesign of Potent and Orally Active GPR119 Agonists for the Treatment of Type II Diabetes.Ping Liu, Zhiyong Hu, Byron G. DuBois, Christopher Moyes, David N. Hunter
ACS Medicinal Chemistry Letters. 2015-07-13
